Category: Boston ScientificSyndicate content

Mixed results for nerve stim in heart failure for Boston Scientific, Cyberonics

September 2, 2014 by Brad Perriello

Vagus nerve stimulation for heart failure flunks a Boston Scientific clinical trial but passes a Cyberonics study, but the question is clouded by the more rigorous, sham-arm structure of the Boston Scientific trial.

Mixed results for nerve stim in heart failure for Boston Scientific, Cyberonics

Secant Medical escapes pelvic mesh cases

September 2, 2014 by Brad Perriello

Secant Medical is dismissed from hundreds of personal injury lawsuits brought over pelvic mesh it made for Boston Scientific and Johnson & Johnson.

Secant Medical escapes pelvic mesh cases

Boston Scientific closes $415 Bayer interventions buy

September 2, 2014 by Brad Perriello

Boston Scientific says it's closed the $415 million acquisition of Bayer AG's interventions unit, nearly doubling the size of its peripherals business.

Boston Scientific closes $415 Bayer interventions buy

Boston Scientific (NYSE:BSX) said today that it closed on the $415 million cash buyout of Bayer AG's interventional unit it announced last May.

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.

Renal denervation isn't dead, despite Medtronic trial's failure

Report: Boston Scientific wins 2nd pelvic mesh bellwether

August 29, 2014 by Brad Perriello

Boston Scientific reportedly wins the 2nd bellwether trial over its Obtryx pelvic mesh device, a month after winning the 1st personal injury case to go to trial over its transvaginal sling devices.

Report: Boston Scientific wins 2nd pelvic mesh bellwether

Boston Scientific lands another date with FDA panel for Watchman stroke device

August 26, 2014 by Brad Perriello

An FDA advisory panel is slated to convene yet again in October to consider the safety and efficacy of Boston Scientific's Watchman anti-stroke heart repair device.

Boston Scientific lands another date with FDA panel for Watchman stroke device

Mirowski asks Supreme Court to hear appeal in lawsuit against Medtronic | Medtech legal news for the week of August 25, 2014

August 25, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Mirowski wants another bite at Supreme Court apple in Medtronic lawsuit; Shareholders sue InVivo Therapeutics, ex-CEO Reynolds over delayed FDA trial; Retractable Technologies urges appeals court to leave infringement win over BD alone; Boston Scientific can't sever Pinnacle pelvic mesh cases; Allergan can't delay shareholder vote on hostile Valeant bid

Mirowski wants another bite at Supreme Court apple in Medtronic lawsuit

August 18, 2014 by Brad Perriello

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp